Fundamentals data is not available for this company.
No recent information was found.
Dynavax, Merck team up on hepatitis B vaccine | 02-Nov-2007 | BayArea.com |
Merck Buys License to Sell New Vaccine for Hepat... | 01-Nov-2007 | New York Times |
Business Digest | 20-Jan-2006 | BayArea.com |
Currency | US Dollars |
Share Price | $ 10.35 |
Change Today | $ 0.17 |
% Change | 1.67 % |
52 Week High | $14.40 |
52 Week Low | $9.36 |
Volume | 100 |
Shares Issued | 65.06m |
Market Cap | $673.41m |
RiskGrade | 699 |
You are here: research